Polarean Imaging (POLX) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Jan 2019 07:00 AM
RNS
Holding(s) in Company
28 Dec 2018 02:52 PM
RNS
Result of General Meeting and Total Voting Rights
11 Dec 2018 07:00 AM
RNS
Conditional Fundraise to raise US$4 million
13 Nov 2018 07:00 AM
RNS
Licencing Agreement with Duke University
06 Nov 2018 07:00 AM
RNS
Company update
05 Nov 2018 07:00 AM
RNS
Nominated Adviser Status
03 Oct 2018 07:00 AM
RNS
Delivery of Xenon Polariser
23 Aug 2018 07:00 AM
RNS
FIRST PATIENT IN PHASE III FDA CLINICAL TRIAL
22 Aug 2018 07:00 AM
RNS
Half-year Report
27 Jul 2018 07:00 AM
RNS
Company update
18 Jul 2018 02:28 PM
RNS
Result of AGM
17 Jul 2018 02:49 PM
RNS
Holding(s) in Company
10 Jul 2018 03:22 PM
RNS
Result of Placing
09 Jul 2018 02:41 PM
RNS
Proposed Placing to raise a minimum of £0.78m
21 Jun 2018 10:12 AM
RNS
Holding(s) in Company
19 Jun 2018 04:40 PM
RNS
Second Price Monitoring Extn
19 Jun 2018 04:35 PM
RNS
Price Monitoring Extension
19 Jun 2018 07:00 AM
RNS
Investor Symposium
13 Jun 2018 07:00 AM
RNS
Final Results
06 Jun 2018 07:00 AM
RNS
Delivery of Xenon Polariser
31 May 2018 07:00 AM
RNS
London Investor Symposium
22 May 2018 07:00 AM
RNS
Delivery of Xenon Polariser
20 Apr 2018 07:00 AM
RNS
Grant of Share Options
17 Apr 2018 07:00 AM
RNS
Polarean technology used in severe asthma study
29 Mar 2018 07:00 AM
RNS
AIM Admission & First Day of Dealings

Polarean Imaging is a medical imaging technology company that develops non-invasive, radiation-free imaging solutions for pulmonary medicine.

Founded in 2016, Polarean is listed in London under the ticker POLX.

POLX share price launched at 14p in 2018.

UK 100

Latest directors dealings